Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study

[1] Kotsopoulos J(2010)Risk factors for ductal and lobular breast cancer: results from the nurses' health study Breast Cancer Res 12 R106-349

[2] Chen WY(2005)The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production Mol Endocrinol 19 340-43

[3] Gates MA(2002)Mechanisms involved in the side effects of glucocorticoids Pharmacol Ther 96 23-1570

[4] Tworoger SS(2011)Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science 331 1565-1955

[5] Hankinson SE(2011)Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer J Clin Oncol 29 1949-751

[6] Rosner BA(2010)Insulin-mediated acceleration of breast cancer development and progression in a non-obese model of type 2 diabetes Cancer Res 70 741-1758

[7] Wintermantel TM(2003)Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study Diabetes Care 26 1752-60

[8] Bock D(2009)Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women J Natl Cancer Inst 101 48-1023

[9] Fleig V(2005)No excess risk of breast cancer among female users of systemic glucocorticoids Cancer Epidemiol Biomarkers Prev 14 1022-3600

[10] Greiner EF(2010)Role of glucocorticoids in breast cancer Curr Pharm Des 16 3593-279

[1] Kotsopoulos J(2010)Risk factors for ductal and lobular breast cancer: results from the nurses' health study Breast Cancer Res 12 R106-349

[2] Chen WY(2005)The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production Mol Endocrinol 19 340-43

[3] Gates MA(2002)Mechanisms involved in the side effects of glucocorticoids Pharmacol Ther 96 23-1570

[4] Tworoger SS(2011)Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science 331 1565-1955

[5] Hankinson SE(2011)Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer J Clin Oncol 29 1949-751

[6] Rosner BA(2010)Insulin-mediated acceleration of breast cancer development and progression in a non-obese model of type 2 diabetes Cancer Res 70 741-1758

[7] Wintermantel TM(2003)Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study Diabetes Care 26 1752-60

[8] Bock D(2009)Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women J Natl Cancer Inst 101 48-1023

[9] Fleig V(2005)No excess risk of breast cancer among female users of systemic glucocorticoids Cancer Epidemiol Biomarkers Prev 14 1022-3600

[10] Greiner EF(2010)Role of glucocorticoids in breast cancer Curr Pharm Des 16 3593-279